Role of positron emission tomography in predicting early tumor response to neoadjuvant chemotherapy for breast cancer
Background. Neoadjuvant chemotherapy (NACT) is an important stage in the treatment of patients with breast cancer. Positron emission tomography/computed tomography (PET/СT) with fluorodeoxyglucose labeled with 18F (18F-FDG) is widely used as an effective method of metabolic tumor imaging at the stag...
Saved in:
Main Authors: | N. G. Chanchikova (Author), E. A. Karlova (Author), A. S. Savelyeva (Author), O. A. Silkina (Author), V. I. Chernov (Author), R. V. Zelchan (Author), O. D. Bragina (Author), A. A. Medvedeva (Author) |
---|---|
Format: | Book |
Published: |
ABV-press,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
11C-radiolabeled aptamer for imaging of tumors and metastases using positron emission tomography- computed tomography
by: Anastasia V. Ozerskaya, et al.
Published: (2021) -
Positron emission tomography and positron emission tomography-computerized tomography in pediatric patients
by: Patel Chetan, et al.
Published: (2007) -
Positron Emission Tomography Current Clinical and Research Aspects
Published: (2012) -
Diagnosis of an indistinct Leydig cell tumor by positron emission tomography-computed tomography
by: Jinkyoung Kong, et al.
Published: (2019) -
Positron Emission Tomography Recent Developments in Instrumentation, Research and Clinical Oncological Practice
Published: (2013)